Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
third rock ventures
3
×
cancer
cancer drugs
investing
ipo
revolution medicines
san francisco
san francisco blog main
san francisco top stories
sanofi
the column group
venture capital
warp drive bio
amgen
antisense oligonucleotide
benzodiazepines
biogen
blackstone group
blackstone life sciences
boston
cobimetinib
colorectal cancer
columbia university
david goldstein
deals
depression
epi4k
epilepsy
essential tremor
kiran reddy
major depressive disorder
marcio souza
mark goldsmith
What
medicines
research
3
×
cancer
ipo
proteins
revolution
aims
backed
cancer’s
cause
ceo
despite
disease
drug
drugs
epilepsy
family
frontiers
genes
genetic
hardest
hit
hottest
hunters
known
links
maps
marcio
mutations
neuro
new
parlance
pharmaceutical
play
praxis
precision
ras
reach
reels
revealed
Language
unset
Current search:
research
×
biotech
×
" third rock ventures "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers